Abstract
Spatial –OMICS technologies facilitate the interrogation of molecular profiles in the context of the underlying histopathology and tissue microenvironment. Paired analysis of histopathology and molecular data can provide pathologists with otherwise unobtainable insights into biological mechanisms. To connect the disparate molecular and histopathologic features into a single workspace, we developed FUSION (Functional Unit State IdentificatiON in WSIs [Whole Slide Images]), a web-based tool that provides users with a broad array of visualization and analytical tools including deep learning-based algorithms for in-depth interrogation of spatial –OMICS datasets and their associated high-resolution histology images. FUSION enables end-to-end analysis of functional tissue units (FTUs), automatically aggregating underlying molecular data to provide a histopathology-based medium for analyzing healthy and altered cell states and driving new discoveries using “pathomic” features. We demonstrate FUSION using 10x Visium spatial transcriptomics (ST) data from both formalin-fixed paraffin embedded (FFPE) and frozen prepared datasets consisting of healthy and diseased tissue. Through several use-cases, we demonstrate how users can identify spatial linkages between quantitative pathomics, qualitative image characteristics, and spatial --omics
Spatially-resolved, molecular –omics methods are poised to revolutionize medicine both in clinical care and investigative research.1–3 These techniques provide investigators with the ability to analyze biological processes down to subcellular resolution within large regions of interest (ROI).4,5 When further aligned with histology images, spatial molecular data enrich observations of tissue characteristics and lesions, thereby imparting further insights into localized tissue injury responses. However, the high dimensionality of –omics data represents a barrier toward alignment with histologic findings and paired interpretation. When a pathologist interprets a biopsy specimen, information from large whole slide images (WSI), often consisting of over one billion pixels at 40X magnification, is condensed into a few discrete features which inform treatment and diagnostic decisions. Spatial –omics, by comparison, can contain thousands of deep measurements across the entire tissue area. A similar depth of histologic annotation, wherein every cell or functional tissue unit of an organ is manually characterized at the pixel level, would exceed a pathologist’s clinical capacity. Therefore, paired interpretation of spatial –omics and histology data requires the ability to execute queries of each modality of data, mining heterogeneous information in diverse regions of giga-pixel size. Facilitating this complex integration necessitates a tool, allowing users freedom to simultaneously interact and align multimodal information in a scalable, user-friendly interface, where data dimensionality is tractable and comparable. Such a tool will empower users with automated segmentation of tissue structures using deep learning (DL), quantification of tissue characteristics, dimensionality reduction and statistical analysis of spatial data, and merging both modalities of data in a biologically meaningful fashion. To enhance accessibility and interoperability with other data analysis pipelines, the proposed tool should enable integrated histology and derived data output to share results with the broader research community.
We developed a cloud-based visualization and analysis tool, which combines morphological interpretation of functional tissue units (FTU) at high resolution with genome-wide spatial –omics data. This tool, called Functional Unit State Identification for WSIs (FUSION), enables dynamic interaction between users and their data as well as running algorithms with high-computational costs (e.g. GPUs for automated segmentation) utilizing cloud resources (Fig. 1). FUSION was designed in collaboration with the Human BioMolecular Atlas Program (HuBMAP)6 with the goal of aiding users in quantitatively linking spatial –omics datasets to histopathology and determining the distribution of cells and cell states within healthy and diseased tissue. Due to its structural diversity and complex functions, we used the kidney as a prototype organ to demonstrate how FUSION can generate easy-to-interpret visualizations of FTUs with their cellular composition. However, this process may also be applied to spatial –omics datasets from all major organs.
Fig 1. Schematic of FUSION:
FUSION offers cloud-based AI solutions unimodal and multimodal analysis of histology images and associated spatial –omics datasets. (A) Frontend visualization of key features of FUSION, demonstrating qualitative and quantitative analysis of spatial tissue maps based on cell composition. (B) Preprocessing flow diagram for separate processing of histological FTUs and spatial –omics data prior to spatial aggregation and user interaction.
Results
We first discuss a broad system-level overview of FUSION (http://fusion.hubmapconsortium.org), and its various functionalities for diverse users, then describe features that are not available in existing cloud tools for large scale image analytics of digital pathology data. We next use paired, multi-modal histology tissue images and associated 10x Visium spatial transcriptomics (ST) data from kidney tissues of reference (healthy), chronic kidney disease (CKD), and acute kidney injury (AKI) subjects as a vehicle to demonstrate the potential application of FUSION in biological research and molecular pathology.
FUSION
A schematic of FUSION is shown in Fig. 1. Broadly, FUSION is organized into three pages to facilitate a broad array of biological queries of spatial –omics datasets. These pages represent distinct functions that are crucial to the organization and analysis of large datasets, including data uploading, dataset building, and data visualization. Each page allows users to access plugins which are implemented on the backend through a running instance of Digital Slide Archive (DSA).7 On the data uploader page, users can click and drag WSI and associated spatial –omics data files prior to adding slide-level metadata, uploading manual annotations, and/or selecting structures to automatically segment using DL (Fig. 1A). The 10x Visium spatial –omics data contains “spot” (55 μm diameter regions of interest or ROIs) by transcript count matrices, which can be converted into proportions of cell subtypes and their states through a method called cell deconvolution8 (Supp. Doc.). Currently, FUSION hosts 10x Visium ST sample data from both formalin-fixed & paraffin-embedded (FFPE) (n = 12) and frozen (n = 44) kidney biopsy tissues and includes reference (healthy), CKD, and AKI cases. End-users can upload their own data or navigate the processed and quality controlled (QC’d) data in FUSION. Through the dataset builder page, users can assemble their own datasets based on quantitative, aggregated slide characteristics including structure number, abundance of specific cell types within various structures, and morphometric properties and load those slides into a “visualization session” in the data visualization page.
On the visualization page, FUSION enables users to visualize pathomic or cellular feature abundance as a spatial heatmap overlaid on top of the tissue, comparing quantitative cell type and state abundance in various segmented FTUs or manually selected regions (Supp. Fig. 1 & 2). Aggregated cell composition data for each FTU is automatically determined when the user navigates to a new region in the histology image. Additionally, users can generate quantitative morphometrics by selecting individual or multiple morphological features or cell types in the “Morphological Clustering” tools tab and generate violin plots (for individual features) and scatter plots (for two or more features). When more than two features are selected, FUSION uses uniform manifold approximation projection (UMAP) to reduce the selected features into two dimensions. By clicking on individual points or selecting groups of points in the generated data plots, users can view the FTU associated with that point in the plot as well as their cell type and state abundance.
An interactive illustration panel of various regions in the nephron and the corresponding hierarchical ontology is also presented using the framework developed by the Human Reference Atlas (HRA).9 By clicking on different regions within the nephron diagram, users can view a simplified graphic depicting the morphology of cells from that region. This feature increases the utility of this tool for users who are learning more about the cells that contribute to kidney functionality.
FUSION complies with FAIR (findable, accessible, interoperable, reusable) principles. Our approach focusses on modular engineering and systems-level design for computation, scalability, and expansion to enable future integration of novel spatial data from emerging technologies. Codes and documentation for FUSION can be accessed at the GitHub repository: github.com/SarderLab/FUSION
Multi-modal comparison between disease and reference tissues
In the following sections, we present illustrative use-cases of FUSION that integrate histology images and 10x Visium ST data of kidney tissues from reference, CKD (and diabetic) and AKI patients. These data are analyzed separately using sections from 12 FFPE and 23 frozen section slides. For brevity, we only report analysis of FTU-level features in normal and sclerotic glomeruli, which are defined in the Supplemental Document.
Global Comparison of Digital Pathology Image Data
Spatial transcriptomics research yields a large amount of multivariate and bulk measurement data. For decades, pathologists have summarized the histopathologic findings of an entire slide to derive a patient’s prognosis or diagnosis. FUSION embraces this clinically useful approach by enabling high-level, efficient aggregation of multivariate features across a whole slide image. The Dataset Builder page in FUSION facilitates this process in an easy-to-use interface, allowing users to filter datasets based on cell composition and morphometric features recorded across structures within each slide (Fig. 1A). The resulting filtered tissue sections allow visualization and plot generation as well as “local” analysis of histological characteristics within individual slides. To demonstrate this feature, we “globally” assessed our first dataset consisting of diabetic (nd = 4) and reference (nrc = 8) FFPE sections by examining morphometric and cellular features in these datasets (Fig. 2). The total number of sclerotic glomeruli and percentage of sclerotic glomeruli across all glomeruli in each biopsy specimen was assessed. Diabetic samples exhibited greater total sclerotic glomeruli (p < 0.05) and a higher proportion of sclerotic glomeruli (p < 0.05). Using aggregated measurements of cell type composition across different FTUs, FUSION also lets users globally assess specific cell types. When comparing diabetic and reference samples, one particular cell type of interest is the podocyte, a unique epithelial cell found in the kidney’s glomerulus that may become effaced or injured in diabetic kidney disease.10,11 FUSION enables the quantitation of podocyte transcripts in each glomerulus by implementing snRNA-seq deconvolution of spatial transcriptomic data. FUSION was able to identify a reduction in podocyte transcriptional content in sclerotic glomeruli and in non-sclerotic diabetic glomeruli compared to healthy reference tissue (p < 0.05).10,11 This example illustrates how FUSION is able to identify and annotate both pathological and molecular changes in DKD.
Fig. 2. Global comparison of digital pathology image data using Dataset-Builder.
(A) Dataset-Builder page in FUSION with all slides from two selected datasets. (B) Percentage of glomeruli that are sclerotic within each slide, separated by dataset (p < 0.05). (C) Proportion of podocytes in sclerotic and normal glomeruli across reference and diabetes samples. Each dot represents a tissue section.
Structure-Level analysis of Digital Pathology Image Data
At a more granular level, FUSION enables the analysis of distributions of derived features within structures, and the examination of the spatial relationships between those structures. This type of query identifies structural “neighborhoods” which are associated with certain cell types or histomorphological features and can provide insights into pathogenetic mechanisms. Users can select FTU features to analyze, generate figures, and perform statistical analysis on features of biological interests. For a single feature, a violin plot is generated showing the distribution of the selected feature across user-selected labels present in the associated metadata. For two features, a scatter plot is generated to assess linearity between the two selected features. For more than two features, FUSION dimensionally reduces the assembled feature vectors into a UMAP which preserves relative sample variation.12 Users can then use their mouse to select individual data points or “lasso” groups of points to view the image and cell composition associated with that point, or group of points, on the current plot. This type of visualization allows users to associate the quantitative distribution of features with other qualitative findings in individual FTUs. In addition to hypothesis testing, these features can also result in discovery as the clustering is data driven and agnostic and therefore can reveal unanticipated relationships using morphology and molecular datasets.
To demonstrate FUSION’s ability to succinctly and accurately report on histopathology and molecular features, we examined glomerular hypertrophy in reference and DKD samples. Glomerular hypertrophy, or the inordinate growth in tissue, is a manifestation of DKD resulting from mechanical and chemical stresses. To assess for hypertrophy, we measure the area of eosinophilic tissue within each glomerulus (i.e. histological structure). In glomeruli, these eosinophilic regions comprise cell cytoplasm, mesangial matrix, and basement membranes. As expected, diabetic and sclerotic glomeruli depict higher eosinophilic area (Fig. 3),13 coinciding with both the physical enlargement of the glomerulus in response to adaptive hyperfiltration, mesangial expansion, and the loss of both Bowman’s space and open capillary lumens in the setting of glomerulosclerosis.14
Fig. 3. Local comparison of digital histology images using a single feature.
As an example, glomerular hypertrophy is compared in diabetes and reference. Percentage eosinophilic area between normal and sclerotic glomeruli from diabetic and reference kidney tissues. (A-D) Example glomeruli selected from the feature distribution where indicated. Dots represent the individual glomeruli. Sclerosis increases eosinophilic area by reducing open capillary lumens and Bowman”s space. Diabetic kidney disease, in the absence of sclerosis, increases the eosinophilic area through hypertrophy and the expansion of the mesangium. Scalebar indicates 25 μm.
To demonstrate structure-level analysis using multiple morphometric features, we next examine morphological features related to the relative thickness of each sub-compartment. These features are measured using the distance transformation, or the pixel-wise distance from one pixel in a sub-compartment to a pixel of another sub-compartment. Assembled features are first scaled so that each feature has zero mean and unit standard deviation prior to UMAP dimensionality reduction. The resulting scatter plot is then dynamically relabeled in FUSION so that the color of each point corresponds to either disease or structure phenotypes (Fig. 4). These plots may be used to assess data heterogeneity within respective phenotypes and to make inferences on key features within a particular group.
Fig. 4. Local comparison of digital histology images using multiple features.
(A) Frontend interface of FUSION when selecting multiple features for generating plots. UMAP of glomerular sub-compartment distance transform features labeling (B) whether that glomerulus is from a diabetic or reference slide or (C) whether that glomerulus is a normal glomerulus or a sclerotic glomerulus. (D) Images taken from numbered locations in the above plots. Few different sub-groups of glomeruli are observed. These are large sclerotic, small sclerotic, small dense glomeruli, large dense glomeruli, and generally normal glomeruli. Scalebar indicates 25 μm.
One of the first observations derived from the UMAP plot in Fig. 4B–C is that the sclerotic glomeruli predominantly group on the left-hand side along with non-sclerotic glomeruli from diabetic cases. To quantify this observed clustering behavior, silhouette scores are automatically calculated in FUSION and presented alongside other statistical measures and feature summaries in the Plot Report component. For the UMAP containing all glomeruli, silhouette scores of 0.22 and 0.06 are found for the diabetic and reference datasets, respectively, indicating a relatively stronger intra-class grouping of diabetic glomeruli compared to those from reference patients. This observation hints at significant heterogeneity in reference glomeruli, while diabetic glomeruli are concluded to be more homogeneous in this dataset.
FUSION enables the assessment of both inter- and intra-subject variability. For example, we observed within the UMAP that the glomeruli from one reference tissue section grouped together more closely. After selecting these points using the lasso tool, the presence of several red (possibly erythrocytes/RBCs) inclusions are identified within glomerular capillary lumens and are likely artifactual related to tissue preparation (Fig. 4D). It is common that histopathologic specimens will vary in their preparation, staining character, and image quality. FUSION can help to identify artifacts so users can assess whether there is biological relevance or whether artifacts should be excluded or corrected in their analyses.
By selecting other points in the UMAP plot, we can begin to make qualitative conclusions on the relative ordering of glomeruli in the high dimensional scatter (Fig. 4D). Specifically, points sampled from right to left on the lower edge of the UMAP plot seem to depict gradual changes from normal glomeruli to fully sclerotic glomeruli. Furthermore, glomeruli towards the upper side of the UMAP plot seem to have a larger overall area. The tool allows discovery of different sub-groups of glomeruli including large sclerotic, small sclerotic, small dense glomeruli, large dense glomeruli, and generally normal glomeruli. Importantly, because FUSION integrates the molecular features (spatial transcriptomics), one can survey molecular expression in these different morphological variants and infer the molecular changes that may underlie these transitions.
The included examples show FUSION’s ability to conduct spatial data QC, study data heterogeneity, and find patterns using an interactive approach applicable to disease and reference kidney biopsy sections (Fig. 2–4).
Local Comparison of Spatial Molecular Data
After using FUSION for global and local analysis of image morphometrics, our next focus is on the analysis of spatial molecular data and demonstration of multi-modal data integration.
Among the primary cell types of the glomerulus are podocytes and endothelial cells. As described above, normal glomeruli exhibit a significantly higher proportion of podocyte transcript expression when compared to diabetic glomeruli (p < 0.05). Using FUSION’s plotting tool, lasso selection tool, and relative cell composition pie charts, a biomedical scientist user can confirm known changes in cell type composition of diabetic glomeruli, wherein the proportion of podocyte to endothelial cell signature shifts (Fig. 5). This shift reflects two phenomena: a reduction in podocyte transcript expression related to injury and effacement and an increase in glomerular capillary endothelial cell (EC-GC) transcript expression, potentially resultant from neovascularization in diabetic kidney disease.15 Furthermore, a significant difference was found in fibroblast cell fraction between sclerotic and normal glomeruli from both diabetic and reference tissue sections (Fig. 5B).
Fig. 5. Local comparison of spatial molecular data.
Spatial distribution of major cell types in glomerular FTU in our diabetic and reference data. (A) Podocyte proportion in normal and sclerotic glomeruli from reference and diabetic cases. (B) Fibroblast proportion in glomeruli and sclerotic glomeruli from reference and diabetic cases. (C) FUSION frontend example plotting podocyte proportion and endothelial cell proportion with a representative diabetic glomerulus featuring both low podocyte and endothelial cells. Each dot represents a glomerulus. Scalebar indicates 50 μm.
Local Comparison Integrating Pathomic Image Features and Spatial Molecular Data
Integrative analysis is achieved in FUSION by clustering combined morphometric and molecular features. The first UMAP in Fig. 6A was generated using only morphometric features from the distance transform and morphological categories. Diabetic samples are loosely grouped toward the left-hand side of the plot, with some glomeruli intermixed with the reference group. Two separate trends are apparent along the spectrum of reference glomeruli (right) to glomeruli (left), indicating two sub-groups of diabetic glomeruli with distinct morphological appearances.
Fig. 6. Multimodal data FUSION integrating image feature and cell abundance data derived from spatial –omics data.
Glomerular features from both reference and diabetic glomeruli were used to generate UMAP plots. (A) UMAP generated using only morphometric features. (B) UMAP generated using only cell composition features. (C) UMAP generated using a combined set of morphometric and cell composition features. Each dot represents a glomerulus.
When evaluating glomerulus cell composition features (including non-tubule cell types such as podocytes, aggregate endothelial cells, mesangial cells, immune cells, and fibroblasts) (Fig. 6B), we observe heterogeneity in the reference glomeruli resulting in several clusters (upper portion of the plot). Diabetic glomeruli were intermixed, with a subpopulation of glomeruli grouped (bottom right).
Integrating these two modes of data resulted in the strongest separable clustering of diabetic and reference glomeruli. Diabetic glomeruli were grouped towards the upper left-hand portion of the resulting UMAP plot while reference glomeruli spreading between the middle to lower-right portions with some intermixing of the two groups in between (Fig. 6C). By combining morphometrics and cell composition features, silhouette scores for glomeruli in the diabetic group increased from 0.35 with just morphometrics and 0.37 with just cell composition to 0.53. FUSION integrates a common analytical technique found in the Seurat R package, Cluster Markers, to determine key features which separate different groups in dimensionally reduced clusters. This backend implementation offsets the computational costs of this process away from the visualization server, greatly increasing scalability of this process. By selecting the “Find Cluster Markers” button, users can send all data that is used to generate a plot to the backend server in order to determine representative features and their adjusted p-values. In this example of diabetic and reference glomeruli, the significant discriminative features for glomeruli from the diabetic group include both mean and maximum distance transform values for eosinophilic regions (normalized by object area), increased contents of fibroblasts and immune cells, and nuclear morphology. Specifically, some measures of nuclear aspect ratio indicated a departure from circular nuclei to a more elliptical shape. These features consistently demonstrate a change from a normal glomerulus phenotype to that of a typical diabetic glomerulus, often with associated sclerosis/fibrosis, inflammation, and changes in cellular composition. Glomeruli from the reference group exhibited a higher proportion of podocyte transcript expression and reduced fibroblast transcript expression. To query reproducibility, we repeated the clustering of Fig. 6 using slide identity phenotypes as labels of the respective glomeruli and found the expected cluster patterns (Supp. Fig. 3–5).
Spatial Visualization of Immune Cell Infiltration
Thin FFPE sections generally have improved morphology over thick frozen sections. Despite this, FUSION has the sensitivity to distinguish some morphologic features in frozen tissue. In the next use case, 23 kidney samples prepared using a frozen tissue section protocol are derived from individuals with AKI (na = 6), CKD (nc = 11), and reference (nr = 6). The presence and characteristics of inflammation are known to vary greatly between these conditions.16–19 AKI, being an acute pathology, often features acute inflammation in the form of infiltrating lymphocytes, but fewer chronic fibrotic changes.16,17 CKD, by contrast, shows evidence of continual injury over a longer time, manifested as fibrosis throughout the tubulointersitium in the underlying tissue.20,21 The reference tissues may feature some age-related glomerulosclerosis or tubulointerstitial fibrosis, but typically have minimal inflammation.22,23
In Fig. 7A, an example with an overlaid heatmap depicts the 10x Visium spots and glomeruli with greater than 30% immune cell composition. Strong localization of immune cells is seen around a central glomerulus. Fully sclerotic glomeruli in the lower portion of the image exhibit comparatively less immune cell infiltration. This use case illustrates that FUSION is able to identify FTUs and regions of inflammation even with the sub-optimal morphology of a frozen section.
Fig. 7. Spatial visualization of immune cell infiltration.
(A) Screenshot of a CKD section in FUSION with heatmap set to indicate proportion of immune cells. (B) Same view as in (A) but with annotations turned off for better view of underlying histology. Scalebar indicates 200 μm.
Integrating Pathomics and Cell Composition to Study the Impact of Inflammation
Morphological properties can be selected in the clustering tab of FUSION along with non-tubule cell types to generate UMAP visualizations (Fig. 8). Reference glomeruli clustered distinctly from those of diseased samples (Fig. 8A). Cluster markers for these groups revealed statistically significant increased content of immune cells in both AKI and CKD groups compared to the reference glomeruli while the fibroblast content helps to distinguish CKD glomeruli from the AKI glomeruli. FUSION enables users to determine the key features driving clustering (Fig. 8B). In the Reference group, the primary source of heterogeneity between glomeruli stemmed from the different proportions of both podocytes and endothelial cells, both cell types are crucial to normal glomerular function. As expected, the podocyte content of glomeruli in the AKI group (mean = 35.2%) was not substantially lower than that of the reference group (mean = 45.4%). This is expected as changes in podocyte and endothelial cells are often chronic processes, not acute.
Fig. 8. Integrating pathomics and cell composition to study the impact of inflammation.
(A) A UMAP plot generated using combined non-tubule cell type composition and morphologic features of glomeruli from AKI, CKD, and reference groups. Select glomeruli pulled out from indicated locations. Each dot represents a glomerulus. (B-E) Same UMAP as in (A) but with the color of each dot corresponding to the content of (B) podocyte, (C) endothelial cell, (D) fibroblast, and (E) immune cell transcripts. Scalebar indicates 25 μm.
In contrast, more immune cell infiltration was found in AKI glomeruli (mean = 16.1%) compared to reference glomeruli (mean = 1.9%). An increased proportion of fibroblast transcripts were found in CKD glomeruli (mean = 10.9%) compared to both AKI (mean = 6.9%) and reference (mean = 3.2%) which aligns with the increased fibrosis in these samples (Fig. 8C–D).16,17 See in Supp. Fig. 6 the same UMAPs in Fig. 8A–B but using slide identity phenotypes as labels of the respective glomeruli.
Discussion
We present FUSION, a novel visualization, analytic and interactive platform for spatially resolved molecular data that combines histomorphological evaluation with spatial –omics. FUSION empowers a wide variety of users to incorporate spatial –omics into their workflows by providing them with user-friendly tools to reveal underlying pathobiological mechanisms. This process serves to increase the accessibility of quantitative computational analyses to a larger user base which normally requires specific skills.
Continuously linking derived data with the source histology image allows for broad associations of quantitative features with established pathological lesions. For a clinical pathologist, this type of interaction enables more direct comparison of segmented structures from one tissue section with those in other sections. When presented with information from many tissue sections, the extensive data visualization methods implemented in FUSION provide supportive contextual information which can help clarify ambiguity associated with disease severity grading. This is especially true if longitudinal data are available for those other tissue sections in the dataset. An additional benefit of continuously enabling image and quantitative feature association is that it allows users to validate whether a given image morphometric or textural feature is valuable or robust in distinguishing different types of structures or different diseases. Outlier detection is also possible by identifying data points which correspond to images that contain tissue artifacts such as a fold or tear or presence of red blood cells which can interfere with accurate feature calculation. By enabling users to interact with their data at both the level of a single tissue section as well as for dataset comprising of a set of tissue sections, the efficiency and rigor of biological discovery is enhanced.
One strength of FUSION is its extensibility to other modes of spatial –omics. In this work, we present several examples using 10x Visium spatial data which consists of many ROIs covering the tissue. To effectively translate this data to provide users with structural cell composition, we implemented specialized analytical methods for spatial aggregation of molecular data. These aggregation techniques can be expanded for technologies that provide single-cell resolution such as 10x Xenium, CosMx, and Co-Detection by Indexing (CODEX), providing direct insights into cellular composition of complex FTUs.24–26 Moreover, our tool is generalizable for any organ systems with spatial and histology data (Supp. Fig. 7), and such data can be accessed through the HuBMAP portal.27
It is noteworthy to discuss one limitation of FUSION. Namely, due to the requirement for large, annotated, single-nucleus RNA-sequencing (snRNAseq) datasets, cell deconvolution is currently only available for kidney.1 We expect that this deconvolution operation can be expanded for other organ systems with the availability of large scale and comprehensive snRNAseq atlas for other organ systems in the near future.
Through integrations with DSA, FUSION enables users to run complex and computationally intense machine learning algorithms on their own data. The Slicer CLI plugin framework provides computational researchers with a method to share their pipelines with the community in accordance with FAIR principles.28 Further development into the addition and design of new plugins for feature extraction, segmentation, and analysis of spatial –omics data will be the primary aim of future iterations of FUSION.
Methods
Datasets
Input Data Structure
10x Visium data used in the development of FUSION consisted of two separate types of files as input into the pre-processing steps. The first set of files were the high-resolution scanned WSIs. WSIs varied in file extension depending on the brand name of the scanner that was used or due to downstream post-processing (OME-TIFF). Reading these different types of image files can be accomplished through a number of open-source libraries including OpenSlide, Tiffslide, and large-image which is developed by Kitware.7,33 These libraries are capable of opening and extracting image regions for a large variety of file formats. FUSION, through DSA, uses the large-image Python library to read uploaded WSIs, and generate tile sources which are then exposed through an endpoint in the DSA WebAPI.7
The second set of files contain transcriptomics read counts and spot center coordinates. These can either be R Data Serialization (RDS) files (“.rds” file extension) or “h5ad” files downloaded from the HuBMAP data portal. RDS files contain the Seurat object which is output by the Load10X_Spatial() command in Seurat (v4.0).34 Cell subtype proportions for each spot are generated using the TransferData function in Seurat using a large atlas of single-nucleus RNA-seq (snRNA-seq) data gathered from reference patients as a part of the HuBMAP and KPMP consortia.9,31 After this step, the dimensions of the data per-spot are reduced from ~17k transcriptomic read counts to ~70 cell subtypes. These cell subtypes are further grouped together according to a smaller set of main cell types of 16 classes, and a varying number of cell states for each main cell type (Table 2). This manual data reduction technique was chosen to simplify available visualizations while maintaining the most important information in the pertaining tissue sections. As the spots that are integral to the 10x Visium Spatial Transcriptomics technique are much larger than a cell (spot diameter = ~55 μm), each spot is assigned a proportion value for each main cell type that is related to the transcriptomics reads collected at that location.
Table 2.
Breakdown of main cell types, subtypes, and their states.
| Main Cell Types | Sub-Types | States |
|---|---|---|
| Ascending Thin Limb (ATL) | ATL, dATL | Reference, degenerative |
| Connecting Tubule (CNT) | CNT, CNT-PC, dCNT, cycCNT | Reference, degenerative, cycling |
| Distal Convoluted Tubule (DCT) | DCT, DCT1, DCT2, dDCT, cycDCT | Reference, degenerative, cycling |
| Descending Thin Limb (DTL) | DTL, DTL1, DTL2, DTL3, dDTL3 | Reference, degenerative |
| Endothelial Cell (EC) | EC, EC-GC, EC-AEA, EC-DVR, EC-PTC, dEC-PTC, EC-AVR, dEC, cycEC, EC-LYM | Reference, degenerative, cycling |
| Fibroblast (FIB) | FIB, MYOF, cycMYOF, M-FIB, dM-FIB, dM-FIB, aFIB, dFIB | Reference, cycling, degenerative, adaptive |
| Immune (IMM) | IMM, B, PL, T, NKT, MAST, MAC-M2, cycMNP, MDC, cDC, pDC, ncMON, N | Reference, cycling |
| Intercalated Cell (IC) | IC, C-IC-A, CCD-IC-A, CNT-IC-A, dC-IC-A, OMCD-IC-A, M-IC-A, tPC-IC, IC-B | Reference, degenerative, transitioning |
| Neural-like Cells (NEU) | NEU, SC/NEU | Reference |
| Papillary Tip Epithelial (PapE) | PapE | Reference |
| Principal Cell (PC) | PC, C-PC, CCD-PC, OMCD-PC, M-PC, dOMCD-PC, dM-PC, IMCD, dIMCD | Reference, degenerative |
| Parietal Epithelial Cell (PEC) | PEC | Reference |
| Podocyte (POD) | POD, dPOD | Reference, degenerative |
| Proximal Tubule (PT) | PT, PT-S1, PT-S2, PT-S3, aPT, cycPT, dPT, dPT/DTL | Reference, adaptive, cycling, degenerative |
| Thick Ascending Limb (TAL) | TAL, aTAL1, aTAL2, M-TAL, dM-TAL, C-TAL, dC-TAL, MD | Reference, adaptive, degenerative |
| Vascular Smooth Muscle/ Pericyte (VSM/P) | VSM/P, MC, REN, VSMC, VSMC/P, dVSMC | Reference, degenerative |
Kidney cell types and states determined using single cell kidney atlas produced by Lake et. al.1
Spot-level cell type composition data is stored as metadata within the structure annotation text file along with geometry. In FUSION, these are formatted following GeoJSON convention, where each spot is a Feature within a FeatureCollection for each slide. Following automated segmentation of select FTUs, cell type composition data is projected from the spots to intersecting FTUs using a weighted sum, where the weight for each spot is equal to the percentage of FTU-area occupied by that spot. Intersection tests, intersection area, and structural area are calculated using the Shapely package in Python.
Analytics
Cell Deconvolution
Cell deconvolution for 10X Visium spatial transcriptomic counts is carried out using the Seurat package in R. Following normalization and dimensionality reduction using the SCTransform, RunPCA, and RunUMAP functions, identified labels are mapped back to the reference atlas containing sequencing single nucleus information from over 200,000 cells.1 Predicted cell subtype proportions are saved back to the RDS file format and used in conjunction with spot centroid locations to derive spot annotation files containing geometry and cell composition data.
Automated Segmentation of FTUs
Segmentation of FTUs is performed using one of a few plugin implementations of DL deployed using the Slicer CLI Web schema. Each of these models includes PAS-stained kidney sections in their training data. More details on each of the models can be found in Table 3. Our prior work HistoCloud outlines plugin creation using DSA.7,35
Table 3.
FTU segmentation plugins implemented for FUSION.
| Plugin Name | FTUs | Architecture | Reference |
|---|---|---|---|
| MultiCompartment | Cortical interstitium, Medullary interstitium, Glomeruli, Sclerotic Glomeruli, Tubules, Arteries/Arterioles | Detectron2 36 | Lucarelli, et al., Kidney360, 202337 |
| PTC | Peritubular capillaries | U-Net 38 | Chen, et al., Kidney360, 202339 |
| IFTA | Interstitial Fibrosis and Tubular Atrophy (IFTA) | DeepLab V2 40 | Ginley, et al., JASN, 202141 |
Morphometric Feature Extraction
Morphometrics are calculated for each segmented FTU and added to per-structure metadata alongside cell type composition data. These morphometrics are used in the Morphological Clustering tab of FUSION to dynamically cluster structures based on specific morphological characteristics. Morphometrics calculated in this step quantify the size, shape, color and texture of sub-compartments within each segmented FTU. These sub-compartments are segmented using user-defined thresholds during the upload process in an interactive procedure. A full description of these features is provided in Table 4.
Table 4.
Morphometric feature descriptions.
| Feature Name | Sub-Compartments | Group | Description |
|---|---|---|---|
| [ ] Area By Object Area | All | Morphology | Ratio between sub-compartment area and total structural area |
| [ ] Area | All | Morphology | Total area of a given sub-compartment |
| Nuclei Number | Nuclei | Morphology | Number of nuclei contained within a structure |
| Mean Aspect Ratio Nuclei | Nuclei | Morphology | Mean aspect ratio (major axis length divided by minor axis length) across all nuclei within a structure |
| Standard Deviation Aspect Ratio Nuclei | Nuclei | Morphology | Standard deviation of aspect ratio (major axis length divided by minor axis length) across all nuclei within a structure |
| Mean Nuclear Area | Nuclei | Morphology | Mean area of all nuclei within a structure |
| Total Object Area | Total | Morphology | Total area of structure measured in number of pixels |
| Total Object Perimeter | Total | Morphology | Total perimeter of structure boundary measured in number of pixels |
| Total Object Aspect Ratio | Total | Morphology | Aspect ratio (major axis length divided by minor axis length) for a structure |
| Major Axis Length | Total | Morphology | Length of longest axis of ellipse with same normalized second central moments as structure |
| Minor Axis Length | Total | Morphology | Length of shortest axis of ellipse with same normalized second central moments as structure |
| Contrast [ ] | All | Texture | Measures intensity contrast between a pixel and its neighbor over the whole sub-compartment. 0 for ‘constant’ (An image consisting of one color with no variation). |
| Homogeneity [ ] | All | Texture | Measures the closeness of the distribution of elements in the Gray-Level Co-occurrence Matrix (GLCM). 1 for a diagonal GLCM (constant, single color image) |
| Correlation [ ] | All | Texture | Measures how correlated a pixel is to its neighbor over the whole sub-compartment. 1 or −1 for a perfectly correlated image and a perfectly negative correlated image, NaN for a constant image (constant, single color image). |
| Energy [ ] | All | Texture | Sum of the square elements in the Gray-Level Co-occurrence Matrix (GLCM). 1 for a constant, single color image. |
| Mean Red [ ] | All | Color | Mean of red values (first color channel in a RGB image) across a sub-compartment. |
| Mean Green [ ] | All | Color | Mean of green values (second color channel in a RGB image) across a sub-compartment. |
| Mean Blue [ ] | All | Color | Mean of blue values (third color channel in a RGB image) across a sub-compartment. |
| Standard Deviation Red [ ] | All | Color | Standard deviation of red values across a sub-compartment. |
| Standard Deviation Green [ ] | All | Color | Standard deviation of green values across a sub-compartment. |
| Standard Deviation Blue [ ] | All | Color | Standard deviation of blue values across a sub-compartment. |
| Sum Distance Transform By Object Area [ ] | All | Distance Transform | Sum of the distance transform values divided by total object area for a sub-compartment |
| Sum Distance Transform [ ] | All | Distance Transform | Sum of the distance transform values for a sub-compartment. |
| Sum Distance Transform by [ ] Area | All | Distance Transform | Sum of distance transform values for a sub-compartment divided by total area of the same sub-compartment. |
| Mean Distance Transform By Object Area [ ] | All | Distance Transform | Mean of distance transform values for a sub-compartment divided by total object area. |
| Mean Distance Transform By [ ] Area | All | Distance Transform | Mean of distance transform values for a sub-compartment divided by total area of the same sub-compartment. |
| Mean Distance Transform [ ] | All | Distance Transform | Mean distance transform values for a sub-compartment. |
| Max Distance Transform By Object Area [ ] | All | Distance Transform | Maximum distance transform value for a sub-compartment divided by total object area. |
| Max Distance Transform By [ ] Area | All | Distance Transform | Maximum distance transform value for a sub-compartment divided by the total area of the same sub-compartment. |
| Max Distance Transform [ ] | All | Distance Transform | Maximum distance transform value for a sub-compartment. |
Square brackets ([]) indicate the name of each sub-compartment. The sub-compartment denoting ‘Total’ is the boundary of a structure and all its contents.
Frontend
FUSION is built using Dash, a web-based visualization framework for Python applications.42 Components within FUSION are derived from either the core components library or several open-source community components including Dash-Leaflet (for large image visualization), Dash-Bootstrap-Components (for grid-style layouts, icons, and organization), Dash-Extensions (for integrating JavaScript functions), among others.
The visualization page (http://fusion.hubmapconsortium/vis), contains the majority of interactive components in FUSION. These are divided amongst WSI visualization and overlays, interactive plotting, cell graphics and hierarchy viewing, and data downloading. The WSI Viewer card contains the WSI, FTU/spot annotations and their associated overlays, and custom ROIs. Integrated JavaScript functions are used to control boundary color, fill color, transparency, and filtration of overlaid FTU and spot annotations according to user inputs. Annotations and image tiles are hosted in DSA and accessed through the annotations and item tiles WebAPI endpoints. By logging in through FUSION, users can access their personal uploaded images. Although annotation correction is not implemented for FTUs in FUSION, users may correct predicted FTU boundaries using HistomicsUI, which is accessed through DSA at the host address. Combined morphometrics and cell composition plotting is available in the Morphological Clustering tab. In this tab, users can select features, labels, and filters to generate an interactive plot of data in their current dataset. For single features, violin plots of the raw data are generated. Selecting two or more features results in a two-dimensional scatter plot containing either raw data (for two features) or UMAP coordinates for dimensionally reduced data. Users can select one or multiple points to view the FTU or spot with that feature value. By selecting multiple points, an animation is generated that allows the user to scroll through several images or FTUs at a given location at a time (maximum 100 points, for efficiency) as well as view their mean cell composition. This visualization allows users to make broader connections for qualitative observations to the quantitative morphometric or –OMICS values present in a given FTU. Users can also download the cell composition data for FTUs which are in the current view in either Comma Separated Values (CSV) or Excel (XLSX) format. These files will list each FTU in the current view and have a column corresponding to a particular cell.
From the dataset builder page (http://fusion.hubmapconsortium/dataset-builder), users can manually select which datasets they would like to examine in their current visualization session. We provide 56 pre-processed samples from both FFPE and frozen preparations (Table 1) from both healthy, reference and disease groups. After selecting one or more datasets, users can make preliminary visualizations of aggregated metadata including FTU-level cell type composition statistics, counts of each FTU, and other features of interest. This feature can help inform users whether there are certain slides they would like to remove from their current selection. Once a user is satisfied with their collection of slides, they can then click the ‘Go To Visualization’ button to be redirected to the visualization page where their selected slides can be viewed, and their clustering features accessed.
Table 1.
Datasets used in this work.
| Collection | Source | Preparation | FTUs | Patients/Number of sections |
|---|---|---|---|---|
| Reference | HuBMAP | FFPE | Glomeruli, Sclerotic Glomeruli, Tubules, Arteries/Arterioles | 8/8 |
| Diabetic | HuBMAP | FFPE | Glomeruli, Sclerotic Glomeruli, Tubules, Arteries/Arterioles | 4/4 |
| Acute Kidney Injury (AKI) | KPMP | Frozen | Glomeruli | 6/6 |
| Chronic Kidney Disease / Diabetic Kidney Disease (CKD/DKD) | KPMP | Frozen | Glomeruli | 11/11 |
| Reference (Ref) | KPMP | Frozen | Glomeruli | 6/6 |
Pre-processing workflows are accessed through the data upload page (http://fusion.hubmapconsortium/dataset-uploader). Here, users can select what kind of data they would like to upload, upload the required files, select FTUs to segment, select parameters to use to segment sub-compartments within segmented FTUs, and calculate which morphometric features they would like to calculate. All of which is accomplished using simple user-interface components with descriptive instructions throughout.
Backend
FUSION works in concert with a running instance of DSA.7 DSA is a containerized cloud platform which provides users with a secure, flexible, and scalable interface for the analysis of WSIs. Included in DSA is a rich RESTful API (Representational State Transfer Application Programming Interface) and Girder for data management operations. DSA (specifically the Web API) is used by FUSION to store pre-processed and newly uploaded data, run Slicer CLI Web plugins (specially formatted Docker images), access WSI tiles for large image visualization at multiple levels of resolution, and user registration. Using the Girder Client Python library as well as the requests Python library, requests can be made to the DSA server from an external host. This means that the deployment of FUSION and its corresponding DSA instance can have separate resource allocations/specifications which fit what is expected of frontend and backend servers. For example, WSI segmentation jobs are accelerated using graphics processing units (GPUs), and cell deconvolution requires a significantly higher amount of random-access memory (RAM) compared to rendering visualization components on the frontend.
Data, Code, Tutorial, & Promotional Video
Codes for FUSION may be accessed at the GitHub repository: github.com/SarderLab/FUSION. Data used in this project may be accessed through the data portals of participating consortia (portal.hubmapconsortium.org). FUSION can be accessed via http://fusion.hubmapconsortium.org/. A promotional video on FUSION is available at https://www.youtube.com/watch?v=d1tHayLENEE
Supplementary Material
Acknowledgement
We thank the Kidney Precision Medicine Project for providing some of the kidney disease data. Lillian Atchison helped with manuscript editing for final submission. Some of the icons in the cell diagrams are informed and inspired by KPMP.org, Biorender.com, and the Human BioMolecular Atlas Program (HuBMAP).9 TME, SJ, MTE, and RMF were supported by U54DK134301. PS’s work was funded by NIH funding from NIDDK - R21 DK 128668 & R01 DK 114485, and from OD OT2 OD033753.
Footnotes
Disclosure
JET serves in the scientific advisory board Neurovascular Diagnostics, Board of Directors, American Registry of Pathology. PS serves on the advisory board of DigPath Inc., and has ownership interest in this company. FUSION software is protected by ©Copyright 2023 University of Florida Research Foundation, Inc. All Rights Reserved.
References:
- 1.Lake B. B. et al. An atlas of healthy and injured cell states and niches in the human kidney. Nature 619, 585–594 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Bressan D., Battistoni G. & Hannon G. J. The dawn of spatial omics. Science 381, eabq4964 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Wu Y., Cheng Y., Wang X., Fan J. & Gao Q. Spatial omics: Navigating to the golden era of cancer research. Clinical and Translational Medicine 12, e696 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Marx V. Method of the Year: spatially resolved transcriptomics. Nat. Methods 18, 9–14 (2021). [DOI] [PubMed] [Google Scholar]
- 5.Williams C. G., Lee H. J., Asatsuma T., Vento-Tormo R. & Haque A. An introduction to spatial transcriptomics for biomedical research. Genome Medicine 14, 1–18 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Jain S. et al. Advances and prospects for the Human BioMolecular Atlas Program (HuBMAP). Nat. Cell Biol. 25, 1089–1100 (2023). 10.1038/s41556-023-01194-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Gutman D. A. et al. The digital slide archive: a software platform for management, integration, and analysis of histology for cancer research. Cancer Res. 77, e75–e78 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Melo Ferreira R., Freije B. J. & Eadon M. T. Deconvolution tactics and normalization in renal spatial transcriptomics. Frontiers in Physiology 12, 812947 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Börner K. et al. Tissue registration and exploration user interfaces in support of a human reference atlas. Communications Biology 5, 1369 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Dai H., Liu Q. & Liu B. Research progress on mechanism of podocyte depletion in diabetic nephropathy. Journal of diabetes research 2017 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Susztak K., Raff A. C., Schiffer M. & Bottinger E. P. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55, 225–233 (2006). [PubMed] [Google Scholar]
- 12.McInnes L., Healy J. & Melville J. Umap: Uniform manifold approximation and projection for dimension reduction. arXiv preprint arXiv:1802.03426 (2018). [Google Scholar]
- 13.Tervaert T. W. C. et al. Pathologic classification of diabetic nephropathy. J. Am. Soc. Nephrol. 21, 556–563 (2010). [DOI] [PubMed] [Google Scholar]
- 14.Fogo A. B. Glomerular hypertension, abnormal glomerular growth, and progression of renal diseases. Kidney international 57, S15–S21 (2000). [PubMed] [Google Scholar]
- 15.Ferkowicz M. J. et al. Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease. Clinical Journal of the American Society of Nephrology 19, 266–275 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kinsey G. R., Li L. & Okusa M. D. Inflammation in acute kidney injury. Nephron Experimental Nephrology 109, e102–e107 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Zuk A. & Bonventre J. V. Acute kidney injury. Annu. Rev. Med. 67, 293–307 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Akchurin O. M. & Kaskel F. Update on inflammation in chronic kidney disease. Blood purification 39, 84–92 (2015). [DOI] [PubMed] [Google Scholar]
- 19.Mihai S. et al. Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. Journal of immunology research 2018. (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Eddy A. A. Progression in chronic kidney disease. Advances in chronic kidney disease 12, 353–365 (2005). [DOI] [PubMed] [Google Scholar]
- 21.Panizo S. et al. Fibrosis in chronic kidney disease: pathogenesis and consequences. Int J Mol Sci 22, 408 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kaplan C., Pasternack B., Shah H. & Gallo G. Age-related incidence of sclerotic glomeruli in human kidneys. The American journal of pathology 80, 227 (1975). [PMC free article] [PubMed] [Google Scholar]
- 23.Kremers W. K. et al. Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy: the Aging Kidney Anatomy study. Nephrol Dial Transpl 30, 2034–2039 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Black S. et al. CODEX multiplexed tissue imaging with DNA-conjugated antibodies. Nat. Protoc. 16, 3802–3835 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Salas S. M. et al. Optimizing Xenium In Situ data utility by quality assessment and best practice analysis workflows. BioRxiv, 2023–2002 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Rosenbloom A. et al. A complete pipeline for high-plex spatial proteomic profiling and analysis of neural cell phenotypes on the CosMx™ Spatial Molecular Imager and AtoMx™ Spatial Informatics Platform. Alzheimer’s & Dementia 19, e076665 (2023). [Google Scholar]
- 27.Project, H. B. A. <https://portal.hubmapconsortium.org>(
- 28.Jacobsen A. et al. Vol. 2 10–29 (MIT Press One Rogers Street, Cambridge, MA 02142–1209, USA: journals-info …, 2020). [Google Scholar]
- 29.Börner K. et al. Anatomical Structures, Cell Types, and Biomarkers Tables Plus 3D Reference Organs in Support of a Human Reference Atlas. bioRxiv, 2021.2005.2031.446440 (2021). 10.1101/2021.05.31.446440 [DOI] [Google Scholar]
- 30.The Human BioMolecular Atlas Program, <https://commonfund.nih.gov/HuBMAP> (
- 31.de Boer I. H. et al. Rationale and design of the kidney precision medicine project. Kidney Int. 99, 498–510 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kidney Precision Medicine Project, <https://kpmp.org/> (
- 33.Goode A., Gilbert B., Harkes J., Jukic D. & Satyanarayanan M. OpenSlide: A vendor-neutral software foundation for digital pathology. Journal of pathology informatics 4, 27 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Seurat (V 3.2.3), <https://satijalab.org/seurat/> (
- 35.Lutnic B. et al. A user-friendly tool for cloud-based whole slide image segmentation with examples from renal histopathology. Communications medicine 2, 105 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Yuxin Wu A. K., Massa Francisco, Lo Wan-Yen, Girschick Ross. Detectron 2, <https://github.com/facebookresearch/detectron2> (2019). [Google Scholar]
- 37.Lucarelli N. et al. Correlating deep learning-based automated reference kidney histomorphometry with patient demographics and creatinine. Kidney360, 10–34067 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Ronneberger O., Fischer P. & Brox T. 234–241 (Springer; ). [Google Scholar]
- 39.Chen Y. et al. Clinical relevance of computationally derived attributes of peritubular capillaries from kidney biopsies. Kidney360 4, 648–658 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Chen L.-C., Papandreou G., Schroff F. & Adam H. Rethinking atrous convolution for semantic image segmentation. arXiv preprint arXiv:1706.05587 (2017). [Google Scholar]
- 41.Ginley B. et al. Automated computational detection of interstitial fibrosis, tubular atrophy, and glomerulosclerosis. J. Am. Soc. Nephrol. 32, 837–850 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Plotly D. <https://dash.plotly.com>( [Google Scholar]
- 43.Schlöndorff D. Roles of the mesangium in glomerular function. Kidney Int. 49, 1583–1585 (1996). [DOI] [PubMed] [Google Scholar]
- 44.Pavenstädt H. Roles of the podocyte in glomerular function. American Journal of Physiology-Renal Physiology 278, F173–F179 (2000). [DOI] [PubMed] [Google Scholar]
- 45.Pollak M. R., Quaggin S. E., Hoenig M. P. & Dworkin L. D. The glomerulus: the sphere of influence. Clinical Journal of the American Society of Nephrology 9, 1461–1469 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Curthoys N. P. & Moe O. W. Proximal tubule function and response to acidosis. Clinical Journal of the American Society of Nephrology 9, 1627–1638 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Singh V. P., Bali A., Singh N. & Jaggi A. S. Advanced glycation end products and diabetic complications. The Korean journal of physiology & pharmacology: official journal of the Korean Physiological Society and the Korean Society of Pharmacology 18, 1 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.








